Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret, Antony Cicco, F. Kleinclauss, Henk G. van der Poel, Christian G. Stief, Jens Rassweiler, Georg Salomon, Eduardo Solsona,

The Lancet Oncology · 2016 · 330 citations · 16 references

Concepts

References

16